A detailed history of Principal Securities, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 4,360 shares of CRL stock, worth $809,957. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,360
Previous 4,345 0.35%
Holding current value
$809,957
Previous $898 Million 4.32%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$187.96 - $245.29 $2,819 - $3,679
15 Added 0.35%
4,360 $859 Million
Q2 2024

Jul 31, 2024

BUY
$206.39 - $268.73 $6,810 - $8,868
33 Added 0.77%
4,345 $898 Million
Q1 2024

May 10, 2024

BUY
$203.52 - $273.43 $222,040 - $298,312
1,091 Added 33.87%
4,312 $1.17 Billion
Q4 2023

Feb 07, 2024

BUY
$164.52 - $238.84 $529,918 - $769,303
3,221 New
3,221 $761 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.